Kendle International Invites You To Attend An Investor Conference Call And Webcast To Discuss Its Acquisition Of The Phase II-IV Clinical Services Business Of Charles River Laboratories International, Inc.

CINCINNATI, May 10 /PRNewswire-FirstCall/ -- Kendle will conduct a telephone conference call and simultaneous Webcast TODAY, May 10, at 11:30 a.m. Eastern Time to discuss its acquisition of the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. A question and answer session will follow.

(LOGO: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

Webcast Instructions

To access the live Webcast, go to http://www.kendle.com or http://www.videonewswire.com/event.asp?id=33899 . Instructions for accessing the Webcast are provided at both sites. The Webcast will be archived at http://www.kendle.com (click on “Investors”) shortly after the call for on-demand replay through 5 p.m. Eastern Time on June 9. Please note that Webcast participants will not be able to ask questions.

System requirements for the Webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx .

Conference Call Instructions

To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on June 9 by dialing (706) 645-9291 and entering conference ID number 9068977.

About Kendle

Kendle International Inc. is among the world’s leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world’s biopharmaceutical companies maximize product life cycles and grow market share. Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202, or from the company’s Web site at http://www.kendle.com .

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle

CONTACT: Patty Frank, Investors, +1-513-763-1992, or Lori Dorer, Media,+1-513-345-1685

MORE ON THIS TOPIC